TCG Opportunity III GP, LLC
Related Filers (8)
- COLUMN GROUP L P (11)
- NGM BIOPHARMACEUTICALS INC (11)
- COLUMN GROUP III GP, LP (6)
- Column Group Opportunity III GP, LP (6)
- COLUMN GROUP III, LP (6)
- COLUMN GROUP III-A, LP (6)
- Tenaya Therapeutics, Inc. (6)
- Column Group Opportunity III, LP (6)
- Show More ...
Ownership (17)
4
Wednesday, 2/14/2024
Tenaya Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/17/2023
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/14/2023
Tenaya Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/10/2023
Tenaya Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/1/2023
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/25/2023
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 1/23/2023
Tenaya Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/23/2023
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/19/2023
Tenaya Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/12/2023
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/14/2022
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/23/2022
Tenaya Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/23/2022
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/7/2022
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/31/2022
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/27/2022
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities